Etomidate

This classification denotes an anesthetic agent with the molecular formula C14H16N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z22628B598, chemically known as 1h-imidazole-5-carboxylic acid, 1-((1r)-1-phenylethyl)-, ethyl ester but generally known as etomidate, which bears US NIH Compound Identifier 36339. European Medicines Agency schedules Etomidate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07330MIG. The term ETOMIDATE is an International Non-Proprietary Name. World Health Organization schedules etomidate in its Anatomical Therapeutic Chemical (ATC) Classification. ETOMIDATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etomidate under HS 29332990 and SITC 51573. As of Q4 2014, ETOMIDATE remains the US FDA Preferred Term for this commodity. Etomidate bears US NLM identifiers UMLS ID C0015131 and NCI Concept Code C47527. SMILES: O(C(=O)C1N(C(C2CCCCC2)C)CNC1)CC.